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An attractive, though unproven, explanation for the apparent lack of rejection of 
allogeneic fetal tissues by the  mother is that  components of the  placenta normally 
serve to modulate maternal immunity (1).  Evidence in support of a  central role for 
the placenta in the host-parasite relationship of human pregnancy comes from several 
lines of research. For instance, immunohistological investigations of human placentae 
have  revealed  the  presence  of IgG and  complement  within  chorionic  villi  (2)  and 
immunogenetical studies have shown that placental IgG is of both maternal and fetal 
origin (3).  IgG eluted from placentae demonstrates specificity for homologous tropho- 
blast basement membranes (4, 5) indicating the presence of placental-specific antigens, 
and  such  eluates  have been  shown  to  inhibit  lymphocyte blastogenic  responses  to 
tuberculin,  phytohemagglutinin,  and  allogeneic lymphocytes (6).  This  inhibition  is 
apparently caused by antibody, because F  (ab')2 fragments of placental IgG continue 
to inhibit, and Gm typing of eluted IgG indicates that it is predominately maternal 
(6,  7). This suggests that mothers mount vigorous immune responses to fetal antigens 
during normal pregnancies and that evidence of these responses can be identified in 
normal placentae.  However, the nature of the antigens involved is largely unknown. 
To define the placental antigens to which mothers might respond, we have focused 
our attention on the trophoblast, the cell which constitutes the operational interface 
of the host-parasite relationship during human pregnancy. Results of previous studies 
published from this laboratory (8) have resolved the specificity ofheterologous antisera 
to intact and fractionated trophoblast cell membranes into two major antigen groups: 
one  being  common  to  several  human  tissues  including  normal  peripheral  blood 
lymphocytes  (PBL) 1 and  the  other  shared  only  between  trophoblasts  and  certain 
human  cell  lines  maintained  in  vitro.  Because  large  numbers  of trophoblasts  are 
reported  to  pass  into  the  maternal  circulation  during  normal  pregnancy  (9)  it  is 
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reasonable to suspect that mothers might mount specific recognition to these allogeneic 
fetal membranes. Although human trophoblasts lack all known antigens of the major 
histocompatibility complex (10-12), studies with rodent blastocysts have shown that 
certain  of their  minor histocompatibility  antigens  can be serologically identified  on 
trophectoderm  (13).  This indicates  that  maternal  lymphocytes encounter allogeneic 
trophoblast  antigens,  but  neither  the  nature  nor  the  biological  function  of these 
antigens have been studied. We have thus investigated the effects of heterologous anti- 
trophoblast sera on lymphocyte responses to allogeneic cell stimulation. 
Materials  and Methods 
Antisera.  Placentae from normal pregnancies were collected from the delivery theater within 
15  min  of birth.  Trophoblast  microvilli  prepared  by  differential  uhracentrifugation  (14) 
contained large amounts of alkaline phosphatase (15) and exhibited microvilli by transmission 
electron microscopy. They lacked histocompatibility antigens and fla-microglobulin as deter- 
mined by histocompatibility testing,  inhibition of hemagglutination, and radioimmunoassay 
(12),  thereby indicating negligible contamination by membranes from other placental  cells. 
Trophoblast membranes were washed overnight in 3 M  KC1, solubilized in  1% deoxycholate, 
and chromatographed through a column of Bio-Gel P-200 (Bio-Rad Laboratories, Richmond, 
Calif.)  (16). Rabbits were injected with 2 mg each of pelleted trophoblast membranes or with 
1.2 mg of the first peak (known hereafter as peak 1) from Bio-Gel columns. All immunizations 
included 2.5  ml Freund's complete adjuvant containing  1 mg/ml M  tuberculosis,  and were 
boosted intraperitoneally  1 mo later  with  an additional  2 mg of alum-precipitated  antigen 
according to Proom  (17),  and  the animals  were bled  a  fortnight  later.  The antisera  raised 
against pelleted'trophoblast membranes contained precipitating antibodies to IgG, transferrin, 
and alpha-2-macroglobulin as measured by immunoelectrophoresis (IEP) against pooled normal 
human serum (NHS), and in double-radial immunodiffusion (ID) against the purified proteins. 
These  antibodies  were  removed by solid-phase  immunoabsorption  employing a  column  of 
Sepharose (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N.J.)-bound NHS 
(18) until the sera were negative against NHS in IEP and ID. 
All antisera  were heat  inactivated  (56 °  for 30 min)  and  absorbed  with  2  vol of pooled, 
washed, packed human erythrocytes (RBC). Antisera to pelleted trophoblast membranes and 
peak 1 were additionally absorbed twice with PBS (phosphate-buffered saline)-washed lyoph- 
ilized human liver powder, and twice with Ficoll-Hypaque (Pharmacia Fine Chemicals, Div. 
of Pharmacia Inc.) prepared PBL. The PBL absorptions were done by mixing 1 X  10  s cells in 
3 ml of undiluted sera for 40 min at room temperature. In addition,  1 g of lyophilized human 
liver powder washed three times in PBS and packed by uhracentrifugation at  100,000 g for 20 
min was mixed with 3 ml of PBL-absorbed antisera for 1 h at 4°C followed by uhracentrifu- 
gation at  100,000 g for 1 h, and the supernate pipetted and aliquoted into 0.5-ml sterile plastic 
containers and kept at -70°C until use. 
After liver-PBL absorptions,  both antisera  failed to react with  PBL membranes by either 
membrane immunofluorescence or cytotoxicity. Following the tentative nomenclature proposed 
for a group of human trophoblast antigens in a previous publication (8), the liver-PBL absorbed 
antiserum to pelleted, unfractionated trophoblast  membranes is hereafter referred to as anti- 
TA1, and the antiserum  to solubilized, fractionated trophoblast  membranes is referred to as 
anti-peak  I.  Control  hyperimmune  sera  were  obtained  from  four  rabbits  that  had  been 
immunized with frozen-thawed X3, washed HEp-2 cell membranes and absorbed and processed 
exactly  as  the  anti-TAx  and  anti-peak  1 sera.  Additional  control  (nonimmune)  sera  were 
obtained  from a  pool of 10 unimmunized  healthy rabbits.  All sera used  in this study were 
ultracentrifuged  at  100,000 g  4°C for 60 min  before use to remove protein  aggregates and 
immune complexes. 
Cells.  Blood was collected  in  acid-citrate-dextrose  solution  and  mononuclear leukocytes 
isolated by Ficoll-Hypaque gradient centrifugation, washed and resuspended to 2.5  ×  106 cell/ 
ml in RPMI  1640 (Grand Island Biological Co., Grand Island, N. Y.) containing 100 mg/ml 
streptomycin and  15% pooled AB human plasma as previously described (19). Stimulator cells 826  ANTIGENS OF HUMAN TROPHOBLAST 
received 3,000 rads in a 137cesium irradiator (M-38-3 Gammator; Isomedix Inc., Parsippany, N. 
J.) to abolish their capacity to proliferate. 
Cytotoxicity.  Microteehniques for complement-dependent cytotoxicity have been described 
in detail (20). Briefly,  1.0 #1 of antisera were incubated at room temperature for 60 min with 
1.0 #1 of cell  suspension  (2.5  X  10n/ml).  After one wash, 2.0/~1 of rabbit  complement were 
added. After an additional  30-min incubation at 37°C, trypan blue in 2% EDTA was added 
and the viability assessed. 
Lymphocyte Cultures.  To determine the effect  of the heterologous antisera in MLC, 250,000 
responder cells  (0.1 ml)  were cultured with  250,000  stimulator cells  (0.1 ml)  in  flat bottom 
mierotiter  trays  (Linbro Chemical  Company, Hamden,  Conn.).  Cultures  were prepared  in 
quadruplicate  and  incubated  in an  air-5%  CO2 incubator for 5 d  at  37°C.  [3H]-thymidine 
(Schwartz/Mann Div., Becton, Dickinson, & Co., Orangeburg, N. Y.) was added (2 #Ci/well) 
and the cells harvested  18 h later in a multiple sample harvester (MASH II, Microbiological 
Associates,  Walkersville, Md.). 
lmmunofluorescence.  For experiments involving cell suspensions,  5 X  105 human PBL, isolated 
as above, were reacted for 20 min with a predetermined optimal dilution of normal rabbit sera 
or anti-trophoblast sera in RPMI-1640 containing 3% fetal calf serum. The cells were washed 
twice in medium and reacted for 20 min with 1:30 dilution of fluorescein-isothioeyanate (FITC) 
conjugated sheep anti-rabbit IgG (Burroughs Weileome Co., Research Triangle Park, N. C.). 
After  three  washes  the  cells  were  suspended  in  50%  glycerol  in  PBS  and  examined  by 
epillumination for membrane immunofluoreseence with a Leitz orthoplan microscope (Leitz/ 
Opto-Metric Industrial Div. of E.  Leitz Inc., Roekleigh, N. J.)  fitted with an FITC dichoric 
mirror and a 54X planapoehromatic objective. Preliminary titrations as done in other tropho- 
blast studies (21) indicated that membrane immunofluorescence experiments could be satisfac- 
torily performed with anti-trophoblast sera at  1:90 dilution and its conjugate at  1:30. 
Immunohistological reactions were done with eryostat sections of fresh placental tissues snap- 
frozen in liquid nitrogen-cooled isopentane. Human placentae were obtained from the Depart- 
ment of Obstetrics, Medical University of South Carolina, baboon (Papio papio) placenta from 
Dr. Vernon Stevens, Department of Obstetrics, Ohio State University, Columbus and rhesus 
(Macaca mulatta) placentae  from  Dr.  Harold  McClure,  Department  of Pathology,  Emory 
University, Atlanta. The preparation of reagents, tissue processing and blocking and absorption 
controls were done according to Faulk and Hijmans (22). The FITC sheep anti-rabbit Ig was 
passed through an immunoabsorption column of Sepharose-bound NHS (18) to insure against 
the possibility that heterophilic antibodies in the conjugate might react with cryostat sections 
of human tissues. Assessment  of reactions was done using transmitted immunofluorescence with 
a  Zeiss universal microscope (Carl  Zeiss,  Inc., N.  Y.)  employing a  75-W xenon light  source, 
FITC primary interference filter, Tiyoda dark ground condensor fitted with a toric lens, and an 
interchangable 530/500 nm barrier filter. 
Results 
Immunofluorescence  Studies.  The apical aspects of syncytiotrophoblast membranes in 
cryostat sections of normal term placentae reacted brilliantly with both anti-TA1 and 
anti-peak  1 at  1:200 dilution,  whereas  no other tissues of the chorionic villi  reacted 
with  these reagents  (Fig.  1).  In addition,  neither  antiserum  reacted with  monkey or 
baboon  placentae,  even  when  employed undiluted.  Unstimulated  peripheral  blood 
lymphocytes from 30 different  donors were studied  by membrane  fluorescence with 
anti-TA1  and  anti-peak  1  by  using  the  same  PBL-liver  absorbed  antisera  that 
produced the intense immunofluorescence of human trophoblasts seen in Fig.  1. The 
positive  control  serum  in  these  experiments  was  unabsorbed  antiserum  to  pelleted 
trophoblast  membranes,  and  the  negative  control  sera  were  trophoblast  absorbed 
anti-trophoblast  serum and normal rabbit serum (NRS). In all instances,  100% of the 
cells reacted with the unabsorbed  positive control antiserum  to pelleted  trophoblast 
membranes  at  1:150 dilution  whereas  none of the cells reacted  with anti-TA1,  anti- JOHN A.  McINTYRE AND W.  PAGE FAULK  827 
Fro.  1.  Cryostat  section  of  term human placenta reacted with 1:200  dilution of  PBL/liver-absorbed 
FITC-labeled rabbit anti-human TAI serum. Identical results were obtained with anti-peak 1  serum 
by indirect immunofluorescence. Note fluorescence limited to the apical aspects of syncytiotropho- 
blast. Fetal stem vessel endothelium (FSV) and cells of villous stroma do not react (X 100). 
peak  1,  trophoblast-absorbed  anti-trophoblast  serum,  or  NRS,  even  when  these 
reagents were used undiluted. 
After the above results with unstimulated  lymphocytes, allogeneically stimulated 
PBL from a  2-h, two-way MLC were harvested and studied  for membrane immu- 
nofluoresence  using  anti-TA1  and  anti-peak  I.  The  unabsorbed  positive  control 
antiserum  to  pelleted  trophoblast  membranes  remained  reactive with  100% of the 
cells,  however, a small number (3-5%) of allogeneically stimulated PBL now reacted 
with  both  anti-TAx  and  anti-peak  1 sera  as  shown  by  a  speckled  distribution  of 
immunofluorescence on  their  membranes,  but  control  reactions  with  trophoblast- 
absorbed anti-trophoblast serum and NRS at  the same or lower dilutions remained 
negative.  In addition, dose-response experiments,  with  the use of lower dilutions of 
anti-TA1 and anti-peak 1 sera, increased the intensity of membrane fluorescence with 
lymphocytes from MLC reactions but had no effect on the total percentage of positive 
cells.  Lymphocytes from control  cultures,  e.g., J Jr  in  Fig.  2,  were  nonreactive  by 
membrane fluorescence with both anti-TA1 and anti-peak  1. 
The specificity of these immunohistological reactions was monitored with positive 
and negative control sera, and all reagents employed in this aspect of the study were 
chromatographed  through  columns  of insolubilized  NHS  to  remove  heterophilic 
antibodies,  and  were  ultracentrifuged  to  remove  possible  immune  complexes  and 
aggregates. The observation that PBL-liver absorbed anti-trophoblast sera react with 
the  membranes  of aUogeneically stimulated  PBL and  not  with  unstimulated  cells 828  ANTIGENS  OF HUMAN TROPHOBLAST 
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Fro.  2.  Inhibition of MLC by anti-peak 1 and anti-TAa sera. Control cells (JJr) from these cultures 
were nonreactive  by membrane  fluorescence with  these antisera,  and  these reagents were not 
eytotoxic for the inhibited (JDr) cells as shown by trypan blue exclusion. NRS and anti-HEp-2 are 
either stimulatory or without effect. Each bar represents the average of quadruplicate  cultures ± 
SEM. 
suggests that trophoblast cross-reactive antigens appear on lymphocytes as a result of 
either  the  recognition  or response  to allogeneic  membranes.  The specificity of this 
reaction  is  further  supported  by  our  previous  report  that  such  trophoblast  cross- 
reactive antigens do not appear on the cell membranes of lectin-stimulated  lympho- 
cytes (23). 
Effect of Anti-Trophoblast Sera on MLC Reactions.  Several experiments were designed 
to  study  the  biological  effects  of  anti-trophoblast  and  control  sera  on  in  vitro 
lymphocyte functions. Anti-TAa and anti-peak  1 sera at  1:50 final dilutions were 90% 
inhibitory in the MLC reaction, whereas NRS and anti-HEp-2 were either stimulatory 
or without  effect  (Fig.  2).  This MLC  inhibition  was reproducible  using lymphocyte 
combinations from at least  10 different donors suggesting that these antisera are not 
capable of recognizing allotypic differences.  We have previously shown  that  prein- 
cubation  of anti-peak  1 with either stimulator  or responder cells has no suppressive 
effect  on MLC  reactions  (23).  These  results  indicate  that  trophoblast  cross-reactive 
lymphocyte  antigens  appear  on  allogeneically  stimulated  lymphocytes  and  that 
antibody to these antigens can significantly inhibit the MLC reactions. Dose-response 
studies  showed  that  [3H]-thymidine uptake  was  totally  inhibited  by increasing  the 
concentration of anti-peak  1 (Fig. 3), and parallel studies of cell viability using trypan 
blue  exclusion  showed  that  the  presence  of anti-TA1  and  anti-peak  1  sera  at  all 
concentrations in Fig. 3 were not cytotoxic. Control cultures with NRS and anti-HEp- 
2  serum  at  identical  concentrations were without  effect, thus making most unlikely 
the possibility that suppression was produced nonspecifically. 
To  further  characterize  the  suppressive  properties  of anti-peak  1,  kinetic  and 
absorption studies were undertaken.  In one set of experiments where anti-peak  1 was 
added to different MLC reactions at hourly intervals, maximal suppression  (85%) was 
observed  between  the  1st  and  6th  h  of culture  (Fig.  4).  Addition  of anti-peak  1 to 
MLC  reactions  after  the  cells  have  been  in  contact  for  >18  h  had  little  or  no 1,000" 
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FIG.  3.  Total inhibition of MLC is obtained by increasing concentrations of anti-peak 1. Each bar 
represents the average of quadruplicate cultures __.  SEM. 
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Fro.  4.  Time-course experiments showing peak  inhibition  by  anti-peak  1  at  2-6  h  and  little 
suppressive effect after 18 h. 
suppressive effect. No suppression was observed in parallel control experiments where 
NRS or anti-HEp-2  sera were added  hourly during the initial  24 h  of culture.  Thus, 
we conclude that trophoblast cross-reactive lymphocyte antigens are transiently found 
on  lymphocyte  membranes,  with  optimal  expression  occurring  between  1 and  6  h 830 
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Fie.  5.  Removal  of anti-peak  1  inhibition  by  absorption  with  trophoblast  membrane  pellet. 
Absorption with PBL or HEp-2 cells are without effect. Bars represent the average of quadruplicate 
cultures +  SEM. 
after an  allogeneic stimulus.  Specificity and  control studies  of MLC  inhibition  by 
anti-trophoblast sera showed that absorption with trophoblast membranes removed 
anti-peak  1 suppression whereas absorptions with HEp-2 cells or PBL had no effect 
(Fig.  5).  These observations provide further support  for the absence of trophoblast 
cross-reactive lymphocyte antigens on unstimulated lymphocytes. 
To test  the biological and  species specificity of anti-peak  1 serum  we conducted 
several experiments with sub-human primates. The effect of anti-peak  1 on monkey 
lymphocytes showed that  both the human  response to rhesus lymphocytes and  the 
rhesus response to human lymphocytes were inhibited by anti-peak 1 (Fig. 6), whereas 
addition of NRS was without effect. Thus, stimulated rhesus lymphocytes may also 
express trophoblast cross-reactive lymphocyte antigens that are similar to those found 
in humans or that anti-peak 1 serum is equally effective in suppressing both stimulator 
and  responder human cells when cocultured with monkey lymphocytes (Fig. 6).  In 
contrast, anti-peak 1 caused no inhibition in [3H]-thymidine incorporation in baboon: 
baboon  reactions  nor  in  MLC  where  baboon  cells  were  responding  to  human 
lymphocytes (Fig. 7). However, positive control experiments showed that the baboon 
lymphocytes used for our studies underwent vigorous MLC reactions when exposed 
to irradiated lymphocytes from either humans  or unrelated baboons.  Furthermore, 
the  addition  of anti-peak  1 was  not  significantly different from  NRS,  presumably 
indicating the lack of human-like trophoblast cross-reactive lymphocyte antigens on 
baboon lymphocytes, suggesting that  the MHC of rhesus lymphocytes may be more 
closely allied  to  human  than  to  baboon  MHC.  Similarly,  significant  increases  in JOHN  A.  McINTYRE AND W.  PAGE  FAULK 
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FIG.  6.  Rhesus:human  MLC responses  are completely abolished by anti-peak  1.  Bars  represent 
the average of quadruplicate cultures  ±  SEM. 
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[3H]thymidine  incorporation  were  observed  when  human  lymphocytes  were  stimu- 
lated  by irradiated  baboon  cells in culture  and  this was  not  inhibited  by anti-peak  1 
sera  (Fig. 8).  Such augmentation  of the MLC  in the presence of anti-trophoblast  sera 
was  never seen  in  human  allogeneic  combinations,  thus,  it  is  possible  that  either  a 832  ANTIGENS  OF  HUMAN  TROPHOBLAST 
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FIG.  8.  Stimulation of human lymphocytes by irradiated baboon cells in the presence of antl-peak 
1 produces significantly greater MLC  reactivity  than  does NRS.  Bars  represent  the average of 
quadruplicate cultures "4- SEM. 
different recognition mechanism exists for human-baboon interactions, or that anti° 
trophoblast sera react differently in this system. 
Discussion 
The phenomenon of antibody enhancement has been invoked by several investi- 
gators as a possible explanation for survival of allogeneic trophoblast in the maternal 
uterus,  and  a  certain  amount  of evidence  has  been  put  forward  to  support  this 
hypothesis (6, 24, 25). A large number of reports have shown blocking factors during 
pregnancy which  inhibit  lymphokine, mitogen,  antigen,  and  MLC  responsiveness, 
and some of these have shown that blocking activity copurifies with the IgG fraction 
of serum  or placental  eluates  (6).  It  is  thus  an  attractive possibility that  antigens 
responsible for these activities are trophoblast membrane components, especially when 
one considers that the trophoblast membrane forms the operational interface between 
the  mother and  fetus for all  mammals with  hemochorial placentae.  However, it  is 
very difficult to interpret any of the above reports in terms of TAa or peak 1 antigens, 
because we have previously shown  that  neither anti-TA1  nor anti-peak  1 interfere 
with lymphokine or mitogen responses (23). Furthermore, it is not presently known 
whether the  mother's immune system  is  even capable  of responding to these  fetal 
antigens, and if she were, it it not apparent whether her responses would benefit or 
destroy  the  trophoblast.  Finally,  it  would  seem  that  histocompatibility-dependent 
reactions to presently known MHC antigens are largely irrelevant to human tropho- 
blast as they are not present on these cells (10-12). 
The precise nature of TA~  is  not  presently clear. We have shown  in  a  previous 
publication that peak  1 contains a  group of glycoproteins that  resolve into at least ,JOHN  A.  McINTYRE  AND  W.  PAGE  FAULK  833 
four bands in sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (16). 
We  know  that  neither  anti-TA1  nor  anti-peak  1  bind  labeled  human  placental 
lactogen, human chorionic gonadotropin, follicle-stimulating hormone, or the placen- 
tal glycoproteins PP5 and SPa by radioimmunoassay, although radio-labeled peak  1 
is  bound  by both  antisera  (W.  P.  Faulk, V.  Stevens,  and J.  A.  McIntyre.  1978. 
Unpublished observations). Although peak  1 contains alkaline phosphatase activity 
(16),  neither anti-peak 1 nor anti-TAx manifest immunohistological, immunocytolog- 
ical, or complement-mediated cytotoxicity effects similar to those achieved with rabbit 
antisera  to  human  placental  alkaline  phosphatase,  suggesting that  the  biological 
effects of our anti-trophoblast sera on lymphocytes are not a result of antibodies with 
specificity for placental alkaline phosphatase. Immunohistological studies with anti- 
TA1 and anti-peak  1 in our laboratory have shown that these reagents do not react 
with cryostat sections of any other normal human tissue except syncytiotrophoblast, 
and  similar  studies  have  shown  that  neither  antisera  reacts  with  trophoblasts  in 
cryostat  sections  of baboon  or  rhesus  placentae.  ~ Although  these  species-specific 
antisera fail to react with other normal tissues, they do however recognize the cell 
membranes of certain human transformed cell lines maintained in vitro  (26,  8).  It 
thus seems  as  though  trophoblasts  contain  a  group  of species-  and  organ-specific 
antigens which we have tentatively designated as TAa  (8),  and that closely related 
trophoblast cross-reactive antigens are found on allogeneically stimulated lymphocytes 
and on certain lines of human transformed cells. 
That lymphocyte TAx is truly a trophoblast cross-reactive antigen is shown by our 
monkey experiments. Although neither anti-TA1 nor anti-peak 1 reacts with monkey 
placentae, they are potent inhibitors of rhesus:human MLC reactions, whether the 
rhesus lymphocytes serve as stimulator or responder cells.  This observation is com- 
patible with an earlier report by Revillard et al. (27) which demonstrated that human 
placental  eluate prolonged  rhesus skin  graft survival  as  well as  inhibited monkey 
MLC and blastogeneic responses to PHA. Unlike placental eluates, neither anti-TA~ 
nor anti-peak  1 inhibit lymphocyte responses to lectins (23), suggesting that tropho- 
blast cross-reactive antigens of human lymphocytes are products of specific cell-cell 
recognition  and  do  not occur simply as  a  result  of either cell culture  or mitogen 
stimulation.Evidence in support of this specificity is drawn from the effects of anti- 
peak  1 on baboon:  baboon and baboon:human MLC reactions. Although baboon: 
baboon  combinations produce  strong  MLC  reactions,  these  are  not  inhibited  by 
human anti-trophoblast sera. In this instance it appears as though human trophoblast 
cross-reactive lymphocyte antigens are not present on MLC-stimulated baboon PBL. 
If human trophoblast cross-reactive antigens fail to appear on lymphocytes subsequent 
to stimulation, as in the case of baboon:human MLC reactions, it is puzzling that 
anti-trophoblast sera then serve as potent stimulators of cellular proliferation. Perhaps 
stimulation rather than suppression occurs if specific recognition of trophoblast cross- 
reactive lymphocyte antigens is incomplete or does not occur between responder and 
stimulator cells.  We  presently  do  not  know  if anti-trophoblast  serum  is  affecting 
stimulator or responder cells. However, our data showing inhibition of MLC by anti- 
trophoblast serum several hours after culture initiation implicates an effect of antibody 
on responder cells,  but the requirement for stimulator cells to be alive (28) suggests 
2 Faulk, W. P., C. Yeager,,J. A. Mclntyre, and M. Ueda.  1978. Human trophoblast antigens in cellular 
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that they may also express trophoblast  cross-reactive antigens, a  process which we 
assume requires metabolic activity and thus cell viability. 
Our interpretation of these results is that human trophoblast contain antigens not 
found on other normal tissues, including unstimulated PBL. This is confirmed by the 
observation that  selectively-absorbed antisera  to either pelleted  trophoblast  mem- 
branes or to solubilized and fractionated trophoblast are neither cytotoxic for lym- 
phocytes nor do they react with cells or tissues other than trophoblasts. Because anti- 
TA1 and anti-peak  1 are potent inhibitors of MLC reactions, it would follow that 
reaction products on lymphocytes are made available subsequent  to MLC. This is 
confirmed by the observation that anti-peak  1 reacts with lymphocyte membranes 
shortly  after  initiation  of MLC,  although  the  same  cells  are  nonreactive  before 
encountering  allogeneic  stimulation.  Our  impression  that these  newly  appearing 
reactive-sites  are  trophoblast  cross-reactive  lymphocyte  antigens  is  further 
strengthened by the observation that they are found on human:rhesus MLC-stimu- 
lated lymphocytes although they are absent from the rhesus placenta. In view of the 
reported absence of MHC antigens on human trophoblast (10-12), it is unlikely that 
the sites which appear after MLC are classical histocompatibility antigens, however, 
their failure to appear after stimulation by baboon lymphocytes suggests that they 
are  associated  with  allogeneic  recognition.  Trophoblast  cross-reactive  lymphocyte 
antigens thus seem to be reaction products of cell-cell interactions, and the nature of 
these antigens appears to be determined by the specficity of the recognition signals 
which initiate the reaction. The role of these antigens in the immunobiology of the 
host-parasite relationship of human pregnancy is largely unexplored. Their role in the 
biology of lymphocyte responses to allogeneic cells may also provide new approaches 
to the study of genetically determined immunological recognition and responsiveness. 
Summary 
This report describes the inhibition of human mixed lymphocyte culture (MLC) 
reactions by rabbit antisera to intact and detergent solubilized, fractionated, human 
trophoblast membranes. Heat-inactivated antisera were passed through solid-phase 
immunoabsorption columns of normal human serum and extensively absorbed with 
human erythrocytes, lymphocytes and liver powder. Immunohistological experiments 
with  these  absorbed  antisera  showed  that  they reacted  brilliantly with  syncytio- 
trophoblast in cryostat sections of human but not baboon or monkey placentae, and 
not with other normal adult tissues including peripheral blood lymphocytes (PBL). 
Addition of these antisera to MLC reactions produced significant and reproducible 
suppression of responses without affecting cell viability. Absorption studies demon- 
strated complete removal of MLC inhibition with trophoblast  membranes but not 
with PBL or suspensions of HEp-2  cells.  Timed experiments showed that optimal 
inhibition occurred when the antisera were added between 2 and 6 h  after culture 
initiation, and that little suppression was achieved after 18 h. Lymphocytes harvested 
from MLC reactions after 2 h showed that 3-5% of the cells reacted with PBL/liver- 
absorbed anti-trophoblast sera, and that unstimulated PBL were negative. Cultures 
of subhuman primate lymphocytes in the presence of heterologous antisera to human 
trophoblast membranes showed total inhibition of rhesus:human and human:rhesus 
MLC, and no suppression of baboon:human or human:baboon reactions, whereas 
human lymphocytes responded in an exaggerated manner when stimulated by baboon JOHN A.  MclNTYRE AND W.  PAGE FAULK  835 
cells.  Modulated  MLC  responses  to human,  rhesus,  or baboon lymphocytes, in  the 
presence of anti-trophoblast sera indicate that the antisera recognize trophoblast cross- 
reactive lymphocyte antigens.  We propose that  these antigens are reaction products 
of cell-cell  interactions,  and  that  the  nature  of the  antigens  is  determined  by  the 
specificity of the recognition signals which initiate the reaction. 
This  work was made possible  through the technical  assistance  of Ms.  C.  Yeager, I.  Lin,  S. 
Mereurio and Mr. G. Fam. Dr. George J. Doellgast, who has described techniques for placental 
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to  human  placental  alkaline  phosphatase.  We  thank  Ms.  Theresa  Caldwell  for excellent 
secretarial assistance in preparation of the manuscript. We would also like to thank Dr. Arthur 
Williams for his support and encouragement during the course of these experiments. 
Received  for publication 16 August  1978. 
References 
1.  Faulk,  W.  P.,  and  M. Jeannet.  1975. Immunological studies  of immunogiobulins  from 
human  placenta.  In  Transmission  of Immunoglobulins  from  Mother  to Young.  W.  A. 
Hemmings, editor. Cambridge University Press,  New York. 47. 
2.  McCormick, J. N., W. P. Faulk, H. Fox, and H. H. Fudenberg.  1971. Immunohistological 
and elution studies of the human placenta.J.  Exp.  Med.  133:1. 
3. Johnson, P. M., J. B. Natvig, U. A. Ystehede, and W. P. Faulk.  1977. Immunobiology of 
human  placentae:  an  immunofluorescence  study  of the  distribution  and  character  of 
immunoglobulins in chorionic villi. Clin. Exp.  Immunol. 30:145. 
4.  Faulk, W. P.  1972. Ontogeny of Acquired Immunity. Excerpta Med.  172. 
5.  Faulk,  W.  P.,  A.  Carbonara,  and  M. Jeannet.  1973. Immunological studies  on  human 
placentae. In Immunology of Reproduction. K. Bratanov, R. G. Edwards, V. H. Vulehanov, 
V. Dikov and B. Somler, editors. Publishing House of the Bulgarian Academy of Sciences, 
Sofia. 405. 
6.  Faulk,  W.  P.,  M. Jeannet,  w.  D.  Creighton,  and  A.  Carbonara.  1974. Immunological 
studies  of the  human  placenta:  characterization  of immunoglobulins  on  trophoblastic 
basement membranes.J.  Clin. Invest. 54"1011. 
7.  Faulk, W. P., M. Jeannet, W. D. Creighton, A. Carbonara, and F.  Hay.  1974. Studies of 
the human placenta, II. Characterization of immunoglobulins on the trophoblastic base- 
ment membrane.,]. Reprod. Fert. 21 (Suppl.):43. 
8.  Faulk, W. P.,  A. Temple, R. E. Lovins, and N. Smith.  1978. Antigens of human tropho- 
blasts: a working hypothesis for their role in normal and abnormal pregnancies. Proc. Natl. 
Acad. Sci. U.S.A.  75:1947. 
9.  Thomas, L., G. W. Douglas, and M. C. Carr.  1959. The continual migration of syncytial 
trophoblasts  from  the  fetal  placenta  into  the  maternal  circulation.  Trans. Assoc. Amer. 
Physicians. 72:140. 
10.  Faulk, W. P., and A. Temple. 1976. Distribution offl~-mieroglobulin and HLA in ehorionic 
villi of human placentae. Nature (Lond.). 262:799. 
11.  Goodfellow, P.  M., C. J.  Barnstable, W. F. Bodmer, D.  E.  Snary, and M. J. Crumpton. 
1976. Expression of HLA system antigens on placenta.  Transplantation (Baltimore). 22:595. 
12.  Faulk, W. P., A. Sanderson, and A. Temple. 1977. Distribution of MHC antigens in human 
placentae.  Transplant. Proc. 9:1379. 
13.  Muggulton-Harris,  A.  L.,  and  M.  H.  Johnson.  1976. The  nature  and  distribution  of 
serologically detectable alloantigens on the preimplantation mouse embryo.J. Embo~ol. Exp. 
Morphol. 35:59. 
14.  Smith, N. C., M. G. Brush, and S. Luckett.  1974. Preparation of human placental villous 
surface membrane. Nature (Lond.). 252:302. 836  ANTIGENS OF HUMAN TROPHOBLAST 
15.  Carlson, R. W., H. G. Wada, and H. H. Sussman. 1976. The plasma membrane of human 
placenta:isolation of microvilious membrane and characterization of protein and  glyco- 
protein subunits.J.  Biol. Chem. 251:4139. 
16.  Faulk,  W.  P.,  R,  E.  Lovins,  C.  Yeager,  and  A.  Temple.  1977. Antigens  of human 
trophoblasts:  Immunological and biochemical characterization.  In  Immunological Influ- 
ence on Human Fertility. B. Boettcher, editor. Academic Press, Inc., New York. 152. 
17.  Proom,  H.  1943. The preparation  of precipitating  sera  for the identification  of animal 
species.J. Pathol. Bacteriol. 55:419. 
18.  Galbraith, G. M. P., R. M. Galbraith, and W. P. Faulk.  1978. The removal of unwanted 
staining in fluorescence microscopy: Solid phase immunoabsorption with normal human 
serum.J.  Clin. Lab. Immunol. 1:163. 
19.  McIntyre, J.  A.  1976. Laboratory techniques.  In  Surgical Immunology. A.  M.  Munster, 
editor. Grune & Stratton, Inc., New York. 283. 
20.  McIntyre, J. A., R. E. Turner, and E. C. LeRoy. 1978. Human leukocyte antigens (HLA), 
I. Biology of the HLA system, II. Clinical applications of HLA typing. South. Med. J.  71: 
1269. 
21.  Faulk,  W.  P.,  and  P.  M. Johnson.  1977. Immunological studies  of human  placentae: 
identification and distribution of proteins in mature chorionic villi.  Clin. Exp. Immunol. 27: 
365. 
22.  Faulk, W. P., and W. Hijmans.  1972. Recent developments in immunofluorescence. Prog. 
Allerg. 16:9. 
23.  McIntyre, J.  A., and  W.  P.  Faulk.  1978. Suppression of mixed lymphocyte cultures  by 
antibodies against human trophoblast membrane antigens.  Transplant. Proc, 10:.919. 
24.  Taylor, P. V., and K. W. Hancock. 1975. Antigenicity of trophoblast and possible antigen- 
masking effects during pregnancy. Immunology 28:973. 
25.  Rocklin, R. E., J. L. Kitzmiller, C. B. Carpenter, M. R. Garovoy, and J. R. David.  1976. 
Absence  of an  immunologic  blocking  factor  from  the  serum  of women  with  chronic 
abortions. N. Engl. J. Med. 295:1209. 
26.  Faulk, W. P., R. E. Lovins, J. M. Goust, and S. K. Ainsworth.  1977. Immunological and 
biochemical studies of human trophoblasts. Fed. Proc. 36:4172. 
27.  Revillard, J. P., J. Brochier, M. Robert, M. Bonneau, and J. Traeger.  1976. Immunologic 
properties of placental eluates.  Transplant. Proc, 8:275. 
28.  Nabholz, M., and V. C. Miggiano. 1977. The biological significance of the mixed leukocyte 
reaction. In B and T  cells  in Immune Recognition. F.  Loor and G. E.  Roelants, editors. 
John Wiley & Sons, Inc., New York. 269. 
29.  Doellgast,  G. J.,  and  W.  H.  Fishman.  1974, Purification  of human  placental  alkaline 
phosphatase: salt effects in affinity chromatography. Biochem. J.  141:103. 
30.  Doellgast,  G. J.,  and  W.  H.  Fishman.  1975, New  chromatographic  approaches  to  the 
separation of human alkaline phosphatase isozymes.  In Isozymes, I. Molecular Structure. 
C. L. Markert, editor. Academic Press,  Inc., New York and London. 293. 